Hypertension in children with congenital adrenal hyperplasia.

Abstract

OBJECTIVES:

Estimates of high blood pressure (BP) incidence in children with congenital adrenal hyperplasia (CAH) vary widely; risk factors are poorly understood. We estimated incidence of hypertension by CAH subtype and sex, and assessed its association with body mass index, hydrocortisone and fludrocortisone.

DESIGN:

Longitudinal.

PATIENTS:

Chart review of 180 paediatric CAH patients (120 salt wasting; 60 simple virilizing; 93 females) seen from 1970 to 2013.

MEASUREMENTS:

High BP was diagnosed by diastolic or systolic blood pressure measurement ≥95th percentile for age, sex and height; hypertension was diagnosed with high BP on at least three clinic visits.

RESULTS:

Children with classic CAH who received fludrocortisone had a significantly higher rate of hypertension (55% vs 31%) than those who did not. Hypertension incidence was higher in salt-wasting CAH (58%) than in simple-virilizing CAH (35%). Hypertension first occurred before age 5 years in 91% of salt-wasting males and 50% of cases in salt-wasting females; most simple-virilizing cases occurred during ages 10-18 years. Rates of hypertension were higher in children who had three or more measurements with 17-OHP < 400 ng/dl (12·12 nmol/l), and this difference was significant in salt-wasting males. Children on fludrocortisone who had three or more readings of 17-OHP < 400 ng/dl (12·12 nmol/l) had a significantly higher rate of hypertension than those who did not. Hydrocortisone dose was not associated with hypertension.

CONCLUSION:

Children with CAH are at higher risk for hypertension than the general paediatric population, and incidence differs by sex and CAH subtype. Hypertension was higher in children on fludrocortisone and who were oversuppressed.

• Authors: Nadia Maccabee-Ryaboy, William Thomas, Jennifer Kyllo, Aida Lteif, Anna Petryk, Maria Teresa Gonzalez-Bolanos, Peter C Hindmarsh, Kyriakie Sarafoglou
• Journal: Clinical endocrinology (Clin Endocrinol (Oxf)) Vol. 85 Issue 4 Pg. 528-34 (Oct 2016) ISSN: 1365-2265 [Electronic] England
• PMID: 27105393 (Publication Type: Journal Article, Multicenter Study)
• Copyright: © 2016 John Wiley & Sons Ltd.

Chemical References

• 17-alpha-Hydroxyprogesterone
• Fludrocortisone

Topics

• 17-alpha-Hydroxyprogesterone (blood)
• Adolescent
• Adrenal Hyperplasia, Congenital (physiopathology)
• Age Factors
• Child
• Child, Preschool
• Female
• Fludrocortisone (adverse effects, pharmacology, therapeutic use)
• Humans
• Hypertension (chemically induced, etiology)
• Infant
• Infant, Newborn
• Longitudinal Studies
• Male
• Retrospective Studies
• Sex Factors